Autologous mononuclear bone marrow cells during reparative regeneratrion after acute myocardial infarction
Related Experiment Video
Updated: Aug 8, 2026

07:50
Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
R S Karpov1, S V Popov, V A Markov
1Institute of Cardiology, Tomsk Research Center, Siberian Division of the Russian Academy of Medical Sciences.
Bulletin of Experimental Biology and Medicine
|June 9, 2006
Abstract:
A randomized controlled study included 44 patients with acute myocardial infarction. It was found that intracoronary injection of bone marrow mononuclear cells is safe, ensures fixation of the injected cells in the myocardium, reduces blood levels of IL-1beta and TNF-alpha, increases the content insulin-like growth factor, and does not provoke malignant arrhythmias.

